Triad Investment Management Makes New $4.93 Million Investment in Danaher Corporation $DHR

Triad Investment Management bought a new stake in Danaher Corporation (NYSE:DHR) in the fourth quarter, HoldingsChannel.com reports. The fund bought 21,540 shares of the conglomerate’s stock, valued at approximately $4,931,000. Danaher comprises 5.0% of Triad Investment Management’s holdings, making the stock its 6th biggest holding.

Several other institutional investors and hedge funds have also recently bought and sold shares of the company. JPL Wealth Management LLC bought a new position in Danaher in the 3rd quarter worth approximately $25,000. WFA of San Diego LLC bought a new position in Danaher during the second quarter valued at about $26,000. Howard Hughes Medical Institute acquired a new position in Danaher during the second quarter worth about $27,000. ANTIPODES PARTNERS Ltd bought a new stake in Danaher in the third quarter worth about $27,000. Finally, TruNorth Capital Management LLC acquired a new stake in Danaher in the 3rd quarter valued at about $28,000. Institutional investors own 79.05% of the company’s stock.

Danaher Stock Performance

Shares of DHR opened at $190.88 on Thursday. The company has a 50-day moving average of $206.34 and a two-hundred day moving average of $214.45. The stock has a market cap of $135.08 billion, a price-to-earnings ratio of 37.87, a PEG ratio of 2.57 and a beta of 0.93. The company has a debt-to-equity ratio of 0.35, a current ratio of 1.87 and a quick ratio of 1.51. Danaher Corporation has a one year low of $171.00 and a one year high of $242.80.

Danaher (NYSE:DHR) last released its quarterly earnings results on Tuesday, January 27th. The conglomerate reported $2.23 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.14 by $0.09. The business had revenue of $6.84 billion for the quarter, compared to analyst estimates of $6.79 billion. Danaher had a net margin of 14.71% and a return on equity of 10.81%. The firm’s revenue was up 4.6% compared to the same quarter last year. During the same quarter in the previous year, the business earned $2.14 earnings per share. On average, equities research analysts expect that Danaher Corporation will post 7.63 earnings per share for the current year.

Danaher Increases Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, April 24th. Stockholders of record on Friday, March 27th will be given a $0.40 dividend. This represents a $1.60 annualized dividend and a dividend yield of 0.8%. This is a boost from Danaher’s previous quarterly dividend of $0.32. The ex-dividend date of this dividend is Friday, March 27th. Danaher’s payout ratio is 31.75%.

Insider Buying and Selling at Danaher

In related news, EVP Gregory M. Milosevich sold 1,320 shares of the company’s stock in a transaction on Thursday, February 19th. The stock was sold at an average price of $208.01, for a total transaction of $274,573.20. Following the transaction, the executive vice president directly owned 5,099 shares of the company’s stock, valued at approximately $1,060,642.99. The trade was a 20.56% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Corporate insiders own 11.10% of the company’s stock.

Wall Street Analysts Forecast Growth

Several equities analysts have recently issued reports on DHR shares. JPMorgan Chase & Co. lifted their price objective on shares of Danaher from $270.00 to $275.00 and gave the stock an “overweight” rating in a research note on Thursday, January 29th. Guggenheim increased their target price on shares of Danaher from $250.00 to $275.00 and gave the company a “buy” rating in a research note on Friday, January 2nd. Robert W. Baird set a $251.00 price target on shares of Danaher in a research report on Thursday, January 29th. The Goldman Sachs Group cut their price objective on Danaher from $270.00 to $265.00 and set a “buy” rating for the company in a research report on Thursday, January 29th. Finally, Leerink Partners raised their price objective on Danaher from $260.00 to $270.00 and gave the stock an “outperform” rating in a research note on Friday, January 16th. Nineteen equities research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company. According to MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $253.55.

Danaher Profile

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.